Ivanov, Borko ORCID: 0000-0001-8052-8232, Djordjevic, Ilija ORCID: 0000-0002-5810-8626, Eghbalzadeh, Kaveh, Schlachtenberger, Georg, Gerfer, Stephen, Gaisendrees, Christopher ORCID: 0000-0002-7232-3330, Kuhn, Elmar, Rahmanian, Parwis, Sabashnikov, Anton, Mader, Navid and Wahlers, Thorsten . Results and outcomes for patients with atrioventricular groove disruption after mitral valve surgery. Perfusion-UK. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-111X

Full text not available from this repository.

Abstract

Background: Atrioventricular groove disruption (AVGD) is a rare and severe complication of mitral valve surgery (MVS). Current literature is limited to several case reports and series. Our aim was to analyze outcomes of patients with AVGD after MVS from our tertiary cardiac surgery center. Methods: Between June 2010 and January 2019, 18 patients suffering AVGD were identified in our institutional database and included in our retrospective observation. Preoperative, intraoperative and outcome data were analyzed using IBM SPSS Statistics. Late survival was estimated by using the Kaplan-Meier survival analysis. Results: The mean age of the study population was 76 +/- 5 years. Most common indication for MVS was an isolated mitral valve insufficiency (67%). Severe annular calcification was present in four patients (22%). Majority of implanted valves were biological prosthesis (78%). Due to the location, 72% suffered type I rupture. External repair was performed in 94% of all patients. Second look operation in regard of excessive mediastinal hemorrhage was necessary in 67% of patients. Mean hospital stay of the presented collective was 13 +/- 11 days with an intra-hospital mortality of 56%. Late follow-up was obtained in eight patients at an average of 3.1 (1.6-5.7) years postoperatively. Conclusion: Mortality rates for AVGD after MVS are high. However, way of managing AVGD depends on the underlying type of rupture and should be evaluated in regard of the myocardial damage. Due to the rare occurrence, registry data might help to address more scientific value concerning therapeutic measures and outcomes of this severe complication.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Ivanov, BorkoUNSPECIFIEDorcid.org/0000-0001-8052-8232UNSPECIFIED
Djordjevic, IlijaUNSPECIFIEDorcid.org/0000-0002-5810-8626UNSPECIFIED
Eghbalzadeh, KavehUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlachtenberger, GeorgUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gerfer, StephenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gaisendrees, ChristopherUNSPECIFIEDorcid.org/0000-0002-7232-3330UNSPECIFIED
Kuhn, ElmarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rahmanian, ParwisUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sabashnikov, AntonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mader, NavidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wahlers, ThorstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-567004
DOI: 10.1177/0267659121998938
Journal or Publication Title: Perfusion-UK
Publisher: SAGE PUBLICATIONS LTD
Place of Publication: LONDON
ISSN: 1477-111X
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
Cardiac & Cardiovascular Systems; Peripheral Vascular DiseaseMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/56700

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item